Gregory Piazza to Humans
This is a "connection" page, showing publications Gregory Piazza has written about Humans.
Connection Strength
0.123
-
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am Coll Cardiol. 2021 07 27; 78(4):408-411.
Score: 0.008
-
Association of ABO blood group type with cardiovascular events in COVID-19. J Thromb Thrombolysis. 2021 Apr; 51(3):584-586.
Score: 0.007
-
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA. 2020 Dec 22; 324(24):2548-2549.
Score: 0.007
-
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol. 2020 11 03; 76(18):2060-2072.
Score: 0.007
-
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620943671.
Score: 0.007
-
Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities. Eur Heart J. 2019 05 14; 40(19):1515-1517.
Score: 0.007
-
Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction. Thromb Haemost. 2018 Dec; 118(12):2011-2013.
Score: 0.006
-
Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test? Vasc Med. 2018 08; 23(4):388-399.
Score: 0.006
-
Images in Vascular Medicine: A case of Horner's syndrome after catheter-based fibrinolysis for pulmonary embolism. Vasc Med. 2018 10; 23(5):489-490.
Score: 0.006
-
Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism - Coming to consensus when the debate rages on. Vasc Med. 2018 08; 23(4):384-387.
Score: 0.006
-
Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism. J Thromb Thrombolysis. 2018 Feb; 45(2):257-263.
Score: 0.006
-
A midterm report card for pulmonary embolism response teams. Vasc Med. 2018 02; 23(1):72-74.
Score: 0.006
-
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis. Vasc Med. 2017 08; 22(4):324-330.
Score: 0.006
-
Is venous thromboembolism a chronic inflammatory disease? Clin Chem. 2015 Feb; 61(2):313-6.
Score: 0.005
-
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
Score: 0.002
-
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141.
Score: 0.002
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
Score: 0.002
-
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.
Score: 0.002
-
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 12; 196:382-394.
Score: 0.002
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
Score: 0.002
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
Score: 0.002
-
Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. Circulation. 2019 11 12; 140(20):e774-e801.
Score: 0.002
-
Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension. Chest. 2019 08; 156(2):200-202.
Score: 0.002
-
Andexanet Alfa (Andexxa) Formulary Review. Crit Pathw Cardiol. 2019 06; 18(2):66-71.
Score: 0.002
-
Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients. J Thromb Thrombolysis. 2019 Feb; 47(2):331-335.
Score: 0.002
-
Let's Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked. Circulation. 2018 12 04; 138(23):2591-2593.
Score: 0.002
-
Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. Am J Med. 2018 12; 131(12):1408-1417.
Score: 0.002
-
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. JACC Cardiovasc Interv. 2018 07 23; 11(14):1401-1410.
Score: 0.002
-
Surgical pulmonary embolectomy and catheter-directed thrombolysis for treatment of submassive pulmonary embolism. J Card Surg. 2018 May; 33(5):252-259.
Score: 0.002
-
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis. Circulation. 2018 02 13; 137(7):684-692.
Score: 0.001
-
Risk Stratification Model: Lower-Extremity Ultrasonography for Hospitalized Patients with Suspected Deep Vein Thrombosis. J Gen Intern Med. 2018 01; 33(1):21-25.
Score: 0.001
-
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients. J Vasc Interv Radiol. 2017 Sep; 28(9):1248-1254.
Score: 0.001
-
The evidence supporting treatment of reflux and obstruction in chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2017 05; 5(3):399-412.
Score: 0.001
-
Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan; 41(1):68-80.
Score: 0.001